TY  - JOUR 
AU  - Pugliesi, A.
AU  - de Oliveira, A.B.
AU  - Oliveira, A.B.
AU  - Xavier, R.
AU  - da Mota, L.M.H.
AU  - Bertolo, M.B.
AU  - González-Gay Mantecón, Miguel Ángel
AU  - Citera, G.
AU  - de Carvalho, L.S.F.
PY  - 2023
SN  - 2523-3106
UR  - http://hdl.handle.net/20.500.11940/21249
AB  - Background: Our aim was to compare the efficacy of rituximab, tocilizumab, and abatacept in individuals with rheumatoid arthritis (RA) refractory to treatments with MTX or TNFi agents. Methods: We searched 6 databases until January 2023 for phase 2-4...
LA  - eng
KW  - Humans
KW  - Abatacept
KW  - Rituximab
KW  - Methotrexate
KW  - Tumor Necrosis Factor Inhibitors
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
TI  - Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
DO  - 10.1186/s42358-023-00298-z
T2  - Advances in Rheumatology
KW  - AS Santiago
KW  - CHUS
VL  - 63
ER  -